Management of Generalised Anxiety Disorder with Shirodhara and Sarvanga Abhyanga

Ã¢â?¬Å?A clinical study to evaluate the effect of Shirodhara along with Abhyanga in the management of Generalised Anxiety Disorder(Atatvabhinivesh)"

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/045565

Enrollment

Registered

2022-09-15

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Post Covid Patients 2 Patients with symptoms of Generalised Anxiety Disorder 3 Hypertensive Patients

Exclusion criteria

Exclusion criteria: 1 Patients having serious systemic diseases like cardiac, renal or respiratory 2 Patients unsuitable for Shirodhara and Abhyanga 3 Patients taking any other treatment of Generalised Anxiety Disorder

Design outcomes

Primary

Measure	Time frame
Subjective Criteria Hamilton Anxiety Rating ScaleTimepoint: 21 Days	—

Secondary

Measure	Time frame
To find out the efficacy of treatment in 30 patients with the help of Hamilton Anxiety Rating ScaleTimepoint: 21 Days	—

Countries

India

Contacts

Public ContactManvi Yadav

UPGIAS&R DSRRAU

atreyagyan@gmail.com9829798701

Outcome results